Readystate Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$736K Buy
+800
New +$811K 0.03% 426
2025
Q2
Sell
-4,200
Closed -$3.47M 792
2025
Q1
$3.47M Buy
4,200
+1,400
+50% +$1.16M 0.12% 160
2024
Q4
$2.16M Sell
2,800
-12,800
-82% -$10.6M 0.07% 291
2024
Q3
$13.8M Buy
15,600
+14,600
+1,460% +$13.1M 0.26% 137
2024
Q2
$905K Sell
1,000
-32,300
-97% -$25.8M 0.03% 340
2024
Q1
$25.9M Buy
33,300
+23,700
+247% +$16.9M 0.37% 29
2023
Q4
$5.6M Buy
+9,600
New +$5.6M 0.19% 113
2023
Q2
Sell
-900
Closed -$309K 348
2023
Q1
$309K Buy
+900
New +$304K 0.03% 250

Other funds holding LLY

Readystate Asset Management's LLY Position: Q2 2025 in Review

Readystate Asset Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 641 shares — an estimated $529K sold.

Readystate Asset Management first reported a position in LLY in Q4 2023 and held it in 4 quarters. The position peaked at $626K in Q4 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Readystate Asset Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 641 Eli Lilly shares in Q2 2025, an estimated $529K.
  • Readystate Asset Management first reported a position in Eli Lilly in Q4 2023 and held it in 4 quarters.
  • Readystate Asset Management's Eli Lilly position peaked at $626K in Q4 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.